TGA safety alert: GLP-1 medicines and rare, severe vision loss
The TGA has issued a safety update about a potential association between glucagon-like peptide-1 receptor agonist medicines—commonly known as GLP-1 RAs—and non-arteritic anterior ischaemic optic neuropathy (NAION).









